4 results
To evaluate the safety and efficacy of 177Lu-PSMA RLT in patients with R/M ACC and SDC with PSMA ligand uptake.
The main objective of this Phase IIa/b study is to demonstrate the effectof zibotentan on HVPG, and that dapagliflozin can mitigate fluid retention safety concernsregarding its use in this population.
The primary objective is: To obtain 256 simultaneously recorded body-surface ECGs and a torso-heart geometry (determined by CT scan) in patients, to develop and validate mathematical algorithms that can reconstruct epicardial electrical potentials.…
To determine whether dapagliflozin is superior to placebo in reducing the incidence of the primary composite endpoint of kidney failure, hospitalization for heart failure, and all-cause mortality in the overall patient group, consisting of patients…